Birdwatch Note
2024-11-14 06:02:30 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
le paxlovid a démontré son efficacité dans le traitement des patients ayant un risque élevé de développer une forme grave de COVID et ne nécessitent pas d'oxygénothérapie. C'est pour cette indication qu'il a reçu l'autorisation de mise sur le marché https://sfpt-fr.org/covid19-foire-aux-questions/1602-181-qu-est-ce-que-le-paxlovid%C2%AE-est-il-efficace-pour-traiter-la-covid-19
Written by 51D5BF872806600EBE195059D4DA6775990893F9B83C8320BF10DB3D003D78AF
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1856757719547490377
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1856940753475240242
- noteId - 1856940753475240242
- participantId -
- noteAuthorParticipantId - 51D5BF872806600EBE195059D4DA6775990893F9B83C8320BF10DB3D003D78AF
- createdAtMillis - 1731564150576
- tweetId - 1856757719547490377
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- le paxlovid a démontré son efficacité dans le traitement des patients ayant un risque élevé de développer une forme grave de COVID et ne nécessitent pas d'oxygénothérapie. C'est pour cette indication qu'il a reçu l'autorisation de mise sur le marché https://sfpt-fr.org/covid19-foire-aux-questions/1602-181-qu-est-ce-que-le-paxlovid%C2%AE-est-il-efficace-pour-traiter-la-covid-19
Note Ratings
| rated at | rated by | |
| 2024-11-14 09:13:05 -0600 | Rating Details | |
| 2024-11-14 08:20:59 -0600 | Rating Details | |
| 2024-11-14 08:19:47 -0600 | Rating Details | |
| 2024-11-14 07:04:14 -0600 | Rating Details | |
| 2024-11-14 07:02:04 -0600 | Rating Details | |
| 2024-11-14 06:32:18 -0600 | Rating Details | |
| 2024-11-14 06:15:30 -0600 | Rating Details | |
| 2024-11-14 05:45:36 -0600 | Rating Details | |
| 2024-11-14 05:43:08 -0600 | Rating Details | |
| 2024-11-14 03:19:50 -0600 | Rating Details | |
| 2024-11-14 03:15:25 -0600 | Rating Details | |
| 2024-11-14 03:12:38 -0600 | Rating Details | |
| 2024-11-14 02:43:44 -0600 | Rating Details | |
| 2024-11-14 02:29:27 -0600 | Rating Details | |
| 2024-11-14 01:47:28 -0600 | Rating Details | |
| 2024-11-14 01:33:26 -0600 | Rating Details | |
| 2024-11-14 01:29:14 -0600 | Rating Details | |
| 2024-11-14 01:04:39 -0600 | Rating Details | |
| 2024-11-14 00:51:47 -0600 | Rating Details | |
| 2024-11-14 00:35:03 -0600 | Rating Details | |
| 2024-11-14 00:29:57 -0600 | Rating Details | |
| 2024-11-15 04:19:31 -0600 | Rating Details | |
| 2024-11-14 21:05:37 -0600 | Rating Details | |
| 2024-11-14 06:41:13 -0600 | Rating Details | |
| 2024-11-14 05:35:31 -0600 | Rating Details | |
| 2024-11-14 04:53:49 -0600 | Rating Details | |
| 2024-11-14 04:01:25 -0600 | Rating Details | |
| 2024-11-14 01:51:12 -0600 | Rating Details | |
| 2024-11-14 01:31:42 -0600 | Rating Details | |
| 2024-11-14 01:06:05 -0600 | Rating Details | |
| 2024-11-14 00:27:18 -0600 | Rating Details | |
| 2024-11-14 13:51:12 -0600 | Rating Details | |
| 2024-11-14 10:38:25 -0600 | Rating Details | |
| 2024-11-14 10:22:11 -0600 | Rating Details | |
| 2024-11-14 04:38:48 -0600 | Rating Details | |
| 2024-11-14 02:20:31 -0600 | Rating Details | |
| 2024-11-14 01:29:55 -0600 | Rating Details | |
| 2024-11-14 01:05:19 -0600 | Rating Details | |
| 2024-11-14 01:02:26 -0600 | Rating Details | |
| 2024-11-14 00:58:11 -0600 | Rating Details | |
| 2024-11-14 00:39:11 -0600 | Rating Details | |
| 2024-11-14 00:30:16 -0600 | Rating Details |